Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rixci Ramirez"'
Autor:
Cesar Arce Sandoval, Mónica Isabel Meneses Medina, Miriam Heidi Cisneros Cordero, Jorge Humberto Hernandez-Felix, Vanessa Rosas Camargo, Lucero Itzel Torres Valdiviezo, Rixci Ramirez, Jesus Alejandro Gabutti Thomas, Fidel David David Huitzil Melendez
Publikováno v:
Journal of Clinical Oncology. 41:644-644
644 Background: liver metastases (LM) from well-differentiated gastroenteropancreatic neuroendocrine tumors (wd-GEP-NET) can develop in 28-77% of patients (pts) in their lifetime. Multiple treatments can provide radiological and symptomatic response.
Publikováno v:
Journal of Clinical Oncology. 39:e16166-e16166
e16166 Background: Worldwide, every year, there are nearly 905,000 patients diagnosed with liver cancer; it is the sixth most common malignancy and the third most lethal malignancy. Almost three quarters of new patients live in areas with low and med
Autor:
Rixci Ramirez, Marisol Gramajo, Carolina Camey, Jennifer Dominguez, Daniel Estuardo Rosales Lopez
Publikováno v:
Journal of Clinical Oncology. 38:e14500-e14500
e14500 Background: In previous studies separately, it has already been determined how the inflammatory response measured by it neutrophilia and also lymphopenia s with temozolamide have determined that they are important at the time of initiation of
Autor:
Daniel Estuardo Rosales Lopez, Rixci Ramirez, Marisol Gramajo, Carolina Camey, Francisco Javier Godinez
Publikováno v:
Journal of Clinical Oncology. 38:318-318
318 Background: Gastric cancer (GC) in Guatemala is the second most common cancer diagnosis and the second leading cause of cancer death in both sexes. It is difficult to determine the exact incidence rate of H. pylori infection‐negative gastric ca
Autor:
Rixci Ramirez, Gustavo Oliva Vega, Alfredo Mansilla, Francisco Godinez Jerez, Daniel Estuardo Rosales Lopez, Carolina Camey
Publikováno v:
Journal of Clinical Oncology. 37:e16117-e16117
e16117 Background: Lymphopenia is associated with toxicity and clinical outcomes in several types of cancer. Decrease in absolute lymphocyte count (ALC) has been observed in the treatment with sunitinib. Objective: characterize lymphopenia ( < 1000/